Medicare Enrolled
Dr. Khurram Wadud, M.D.
Optician · Jacksonville, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wadud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wadud?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wadud
Dr. Khurram Wadud is an optician specialist in Jacksonville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wadud performed 2,504 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wadud received a total of $97,122 from 57 pharmaceutical and/or device companies across 1188 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wadud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 32% volume in FL
$97,122 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,504
Medicare services
Top 32% in FL for optician
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,275 | $89 | $230 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
288 | $26 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $62 | $160 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
185 | $63 | $130 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
183 | $81 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
125 | $83 | $200 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
50 | $92 | $240 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
41 | $110 | $215 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
41 | $35 | $112 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
18 | $48 | $130 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $132 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $139 | $355 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$97,122
Total received (2018-2024)
Avg $13,875/year across 7 years
Top 3% in FL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,188
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,938
2023
$3,598
2022
$19,039
2021
$16,642
2020
$12,081
2019
$19,498
2018
$23,327
Payments by company (2024)
Abbott Laboratories
$384
Lilly USA, LLC
$369
Amgen Inc.
$263
Novo Nordisk Inc
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$221
Insulet Corporation
$203
Medtronic, Inc.
$149
Corcept Therapeutics
$131
Dexcom, Inc.
$110
SANOFI-AVENTIS U.S. LLC
$100
Amneal Pharmaceuticals LLC
$98
Alexion Pharmaceuticals, Inc.
$90
Radius Health, Inc.
$79
Mannkind Corporation
$65
Ascensia Diabetes Care Us Inc.
$65
Tandem Diabetes Care, Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$52
IBSA Pharma Inc.
$50
Antares Pharma, Inc.
$45
Xeris Pharmaceuticals, Inc.
$37
Astellas Pharma US Inc
$34
ABBVIE INC.
$30
Boston Scientific Corporation
$25
Kyowa Kirin, Inc.
$14
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$41,587
Bayer HealthCare Pharmaceuticals Inc.
$28,404
Novo Nordisk Inc
$9,828
Abbott Laboratories
$1,670
SANOFI-AVENTIS U.S. LLC
$1,496
Medtronic MiniMed, Inc.
$1,337
Insulet Corporation
$1,310
Lilly USA, LLC
$1,293
Tandem Diabetes Care, Inc.
$1,178
Boehringer Ingelheim Pharmaceuticals, Inc.
$938
Amneal Pharmaceuticals LLC
$671
Amgen Inc.
$626
Dexcom, Inc.
$623
Horizon Therapeutics plc
$575
Radius Health, Inc.
$573
Xeris Pharmaceuticals, Inc.
$497
MannKind Corporation
$450
AbbVie, Inc.
$345
IBSA Pharma Inc.
$320
Medtronic, Inc.
$315
Antares Pharma, Inc.
$310
Endo Pharmaceuticals Inc.
$293
Corcept Therapeutics
$290
Merck Sharp & Dohme Corporation
$275
Mannkind Corporation
$225
Alexion Pharmaceuticals, Inc.
$180
Bayer Healthcare Pharmaceuticals Inc.
$163
Janssen Pharmaceuticals, Inc
$139
Shire North American Group Inc
$139
Valeritas, Inc.
$138
Astellas Pharma US Inc
$110
AbbVie Inc.
$83
DEXCOM, INC.
$78
Ascensia Diabetes Care Us Inc.
$65
Janssen Scientific Affairs, LLC
$50
Azurity Pharmaceuticals, Inc.
$47
ABBVIE INC.
$44
Acella Pharmaceuticals, LLC
$42
Ipsen Biopharmaceuticals, Inc
$40
Supernus Pharmaceuticals, Inc.
$35
Eisai Inc.
$32
Currax Pharmaceuticals LLC
$28
LifeScan, Inc.
$27
Boston Scientific Corporation
$25
Zealand Pharma US, Inc.
$25
GRT US Holding, Inc.
$24
Merck Sharp & Dohme LLC
$24
Senseonics, Incorporated
$21
Novartis Pharmaceuticals Corporation
$21
Ultragenyx Pharmaceutical Inc.
$17
LIFESCAN, INC.
$16
Relypsa, Inc.
$15
Strongbridge US INC.
$15
Kyowa Kirin, Inc.
$14
Acerus Pharmaceuticals Corporation
$14
BOSTON SCIENTIFIC CORPORATION
$13
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Top 3 companies account for 82.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Adthyza · Androgel · BAQSIMI · BASAGLAR · BYDUREON · Belviq · CONTRAVE · Creon · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EDEX · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · Levemir · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · Myrbetriq · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid 60 · Natesto · ONGLYZA · Omnipod · OneTouch Verio Reflect · Ozempic · Prolia · Qutenza · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TESTOPEL · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · VERQUVO · Veltassa · Veozah · Victoza · WAVEWRITER ALPHA · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
197
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wadud is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wadud experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wadud performed 1,275 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wadud receive payments from pharmaceutical companies?
Yes. Dr. Wadud received a total of $97,122 from 57 companies across 1,188 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wadud's costs compare to other opticians in Jacksonville?
Dr. Wadud's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wadud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Jacksonville
Browse opticians in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology